Harvest Healthcare Leaders Enhanced Income ETF (HHLE)

Harvest Healthcare Leaders Enhanced Income ETF (HHLE $8.69)
- $8.69 P/E (TTM): 72.11X Cap: $59M
- View HHLE Profile
- View Questions on HHLE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Eli Lilly and Company (LLY $732.58)
- $732.58 P/E (TTM): 59.56X Cap: $693.35B
- View LLY Profile
- View Questions on LLY
UnitedHealth Group Incorporated (DE) (UNH $309.87)
- $309.87 P/E (TTM): 12.65X Cap: $280.64B
- View UNH Profile
- View Questions on UNH
Harvest Healthcare Leaders Income ETF (HHL $7.28)
- $7.28 P/E (TTM): 72.11X Cap: $1.42B
- View HHL Profile
- View Questions on HHL
Harvest Healthcare Leaders Enhanced Income ETF (HHLE $8.69)
- $8.69 P/E (TTM): 72.11X Cap: $59M
- View HHLE Profile
- View Questions on HHLE

Q: I hold HHL in my RRIF which is primarily focused on income. I am considering switching HHL to
HHLE. This would increase my income by approximately 30% on this money and allow me to keep the same list of healthcare stocks. Does this make sense; any downsides ; am I missing anything?

As an aside , I am at breakeven with HHL as the sector is under pressure from Trump and also United Healthcare has dampened the sector. But with Trump wanting lower drug prices , the companies will be going overseas to compensate for lower US revenue as witnessed by Eli Lilly raising international prices for Mounjaro.
Thanks .Derek

Read Answer Asked by Derek on August 20, 2025

Royal Bank of Canada (RY $199.58)
- $199.58 P/E (TTM): 21.7X Cap: $281.31B
- View RY Profile
- View Questions on RY
Bank of Nova Scotia (The) (BNS $85.77)
- $85.77 P/E (TTM): 16.5X Cap: $106.83B
- View BNS Profile
- View Questions on BNS
- View Reports on BNS
Canadian Natural Resources Limited (CNQ $43.49)
- $43.49 P/E (TTM): 11.0X Cap: $90.83B
- View CNQ Profile
- View Questions on CNQ
Tourmaline Oil Corp. (TOU $58.32)
- $58.32 P/E (TTM): 14.56X Cap: $21.84B
- View TOU Profile
- View Questions on TOU
Pason Systems Inc. (PSI $11.75)
- $11.75 P/E (TTM): 12.92X Cap: $927M
- View PSI Profile
- View Questions on PSI
- View Reports on PSI
Russel Metals Inc. (RUS $41.60)
- $41.60 P/E (TTM): 14.4X Cap: $2.32B
- View RUS Profile
- View Questions on RUS
Alimentation Couche-Tard Inc. (ATD $69.61)
- $69.61 P/E (TTM): 18.37X Cap: $65.99B
- View ATD Profile
- View Questions on ATD
BMO US High Dividend Covered Call ETF (ZWH $24.13)
- $24.13 P/E (TTM): 50.23X Cap: $1.06B
- View ZWH Profile
- View Questions on ZWH
Dream Industrial Real Estate Investment Trust (DIR.UN $12.26)
- $12.26 P/E (TTM): 25.58X Cap: $3.58B
- View DIR.UN Profile
- View Questions on DIR.UN
- View Reports on DIR.UN
Brookfield Renewable Corporation Class A Exchangeable Subordinate Voting Shares (BEPC $46.29)
- $46.29 Cap: $17.31B
- View BEPC Profile
- View Questions on BEPC
Hamilton Enhanced Canadian Covered Call ETF (HDIV $18.95)
- $18.95 P/E (TTM): 36.38X Cap: $793M
- View HDIV Profile
- View Questions on HDIV
Hamilton Enhanced U.S. Covered Call ETF (HYLD $13.89)
- $13.89 P/E (TTM): 93.22X Cap: $847M
- View HYLD Profile
- View Questions on HYLD
Harvest Healthcare Leaders Enhanced Income ETF (HHLE $8.69)
- $8.69 P/E (TTM): 72.11X Cap: $59M
- View HHLE Profile
- View Questions on HHLE
Hamilton Utilities YIELD MAXIMIZER TM ETF (UMAX $13.59)
- $13.59 P/E (TTM): 65.72X Cap: $810M
- View UMAX Profile
- View Questions on UMAX

Q: I am an 80 year old income investor with some growth. I have $20,000 to employ. The above is a list of my losers out of 50 winners in a portfolio of mostly the Income Portfolio plus 15 yield maximizer ETF's like UMAX. Should I:
1. wait for your monthly advice before acting
2. distribute evenly accross the losers
3. add to the winners
Any other suggestions would be appreciated.
Please take as many credits as needed.
Thank you

Read Answer Asked by STANLEY on March 17, 2025

Amgen Inc. (AMGN $287.71)
- $287.71 P/E (TTM): 23.33X Cap: $154.89B
- View AMGN Profile
- View Questions on AMGN
Merck & Company Inc. (MRK $84.12)
- $84.12 P/E (TTM): 12.13X Cap: $210.11B
- View MRK Profile
- View Questions on MRK
AbbVie Inc 0.500% Senior Notes 2021 (ABBV.21C)
- P/E (TTM): 44.76X
- View ABBV.21C Profile
- View Questions on ABBV.21C
Harvest Healthcare Leaders Enhanced Income ETF (HHLE $8.69)
- $8.69 P/E (TTM): 72.11X Cap: $59M
- View HHLE Profile
- View Questions on HHLE

Q: Hello 5i, I am up quite a bit on MRK, ABBVIE and HHLE. In answer to a question on MRK by Michael on Jan 22 you wrote "We would take a look at AMGN as an alternative to MRK". With the success I have with MRK et al. is MRK a sell to be replaced by AMGN now or is MRK still a keeper for now. Value investor.
Stanley

Read Answer Asked by STANLEY on January 23, 2025